Patents by Inventor Jianpeng DU

Jianpeng DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12234540
    Abstract: The present disclosure relates to a mask, a mask device and a mask design method. The mask includes: a pattern area, wherein the pattern area includes a plurality of openings, among which adjacent openings are spaced apart by a first rib, and at least one of the plurality of openings has a non-straight side, two first straight sides intersecting with the non-straight side, and a second straight side opposite to the non-straight side and intersecting with the first straight sides; and a second rib located at an edge of the pattern area, wherein the second rib is provided with a cutout for compensating for stretch deformation of the non-straight side, extending lines of the two first straight sides extending toward the second rib along a first direction intersect with the second rib to obtain a first area, and the cutout is located at least within the first area.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: February 25, 2025
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Tong Niu, Fengli Ji, Jianpeng Wu, Sen Du
  • Patent number: 9968717
    Abstract: Disclosed is a stent with a drug coating for preventing and treating restenosis, comprising a stent and a drug coating covering the surface of the stent. The active ingredients in the drug coating are guaiane sesquiterpene compounds P1, P2 and P3. P1 is Zedoalactone B, P2 is a stereoisomer of P1, and P3 is Zedoarondiol. Compared with an existing sirolimus eluting stent, the present drug eluting stent can inhibit the intimal hyperplasia and the inflammatory reactions of vascular walls, and promote the endothelialization of blood vessels after the stent is implanted, and thus can prevent the long-term thrombotic complications; and has the advantages of small dosage, low cost, and no toxic side effect.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: May 15, 2018
    Assignee: Xiyuan Hospital of China Academy of Chinese Medical Sciences
    Inventors: Dazhuo Shi, Jiangang Liu, Fuhai Zhao, Xin Wang, Dawu Zhang, Peili Wang, Jianpeng Du, Yuanyuan Cui, Lei Zhang, Kai Cui, Zhengcai Zhang
  • Publication number: 20170216497
    Abstract: Disclosed is a stent with a drug coating for preventing and treating restenosis, comprising, a stent and a drug coating covering the surface of the stent. The active ingredients in the drug coating are guaiane sesquiterpene compounds P1, P2 and P3. P1 is Zedoalactone B, P2 is a stereoisomer of P1, and P3 is Zedoarondiol. Compared with an existing sirolimus eluting stent, the present drug eluting stent can inhibit the intimal hyperplasia and the inflammatory reactions of vascular walls, and promote the endothelialization of blood vessels after the stent is implanted, and thus can prevent the long-term thrombotic complications; and has the advantages of small dosage, low cost, and no toxic side effect.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 3, 2017
    Applicant: XIYUAN HOSPITAL OF CHINA ACADEMY OF CHINESE MEDICAL SCIENCES
    Inventors: Dazhuo SHI, Jiangang LIU, Fuhai ZHAO, Xin WANG, Dawu ZHANG, Peili WANG, Jianpeng DU, Yuanyuan CUI, Lei ZHANG, Kai CUI, Zhengcai ZHANG